A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian c... von Suidan, Rudy S, Ramirez, Pedro T, Sarasohn, Debra M, Teitcher, Jerrold B, Iyer, Revathy B, Zhou, Qin, Iasonos, Alexia, Denesopolis, John, Zivanovic, Oliver, Long Roche, Kara C, Sonoda, Yukio, Coleman, Robert L, Abu-Rustum, Nadeem R, Hricak, Hedvig, Chi, Dennis S

Volltext

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery fo... von Suidan, Rudy S, Ramirez, Pedro T, Sarasohn, Debra M, Teitcher, Jerrold B, Mironov, Svetlana, Iyer, Revathy B, Zhou, Qin, Iasonos, Alexia, Paul, Harold, Hosaka, Masayoshi, Aghajanian, Carol A, Leitao, Mario M, Gardner, Ginger J, Abu-Rustum, Nadeem R, Sonoda, Yukio, Levine, Douglas A, Hricak, Hedvig, Chi, Dennis S

Volltext

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study von Mantha, Simon, Laube, Eva, Miao, Yimei, Sarasohn, Debra M., Parameswaran, Rekha, Stefanik, Samantha, Brar, Gagandeep, Samedy, Patrick, Wills, Jonathan, Harnicar, Stephen, Soff, Gerald A.

Volltext

Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy von Lakhman, Yulia, Akin, Oguz, Park, Kay J, Sarasohn, Debra M, Zheng, Junting, Goldman, Debra A, Sohn, Michael J, Moskowitz, Chaya S, Sonoda, Yukio, Hricak, Hedvig, Abu-Rustum, Nadeem R

Volltext

Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience von Soff, Gerald A., Mones, Jodi, Wilkins, Cy, Devlin, Sean, Haegler‐Laube, Eva, Wills, Jonathan, Sarasohn, Debra M., Juluru, Krishna, Singer, Michael, Miao, Yimei, Batista, Jeanette, Mantha, Simon

Volltext

Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia von Soff, Gerald A., Miao, Yimei, Bendheim, Gemma, Batista, Jeanette, Mones, Jodi V., Parameswaran, Rekha, Wilkins, Cy R., Devlin, Sean M., Abou-Alfa, Ghassan K., Cercek, Andrea, Kemeny, Nancy E., Sarasohn, Debra M., Mantha, Simon

Volltext

A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer C... von Straubhar, Alli M., Filippova, Olga T., Cowan, Renee A., Lakhman, Yulia, Sarasohn, Debra M., Nikolovski, Ines, Torrisi, Jean M., Ma, Weining, Abu-Rustum, Nadeem R., Gardner, Ginger J., Sonoda, Yukio, Zivanovic, Oliver, Chi, Dennis S., Long Roche, Kara

Volltext

Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease von Kumar, Amanika, Sheedy, Shannon, Kim, Bohyun, Suidan, Rudy, Sarasohn, Debra M., Nikolovski, Ines, Lakhman, Yulia, McGree, Michaela E., Weaver, Amy L., Chi, Dennis, Cliby, William A.

Volltext

Prospective Study of the Correlation Between Postoperative Computed Tomography Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, and Peritoneal Carcinom... von CHI, Dennis S, RAMIREZ, Pedro T, BROWN, Carol L, AGHAJANIAN, Carol, GERSHENSON, David M, HOSKINS, William J, HRICAK, Hedvig, BARAKAT, Richard R, TEITCHER, Jerrold B, MIRONOV, Svetlana, SARASOHN, Debra M, IYER, Revathy B, EISENHAUER, Eric L, ABU-RUSTUM, Nadeem R, SONODA, Yukio, LEVINE, Douglas A

Volltext

Is It Time to Centralize Ovarian Cancer Care in the United States? von Cowan, Renee A., O’Cearbhaill, Roisin E., Gardner, Ginger J., Levine, Douglas A., Long Roche, Kara, Sonoda, Yukio, Zivanovic, Oliver, Tew, William P., Sala, Evis, Lakhman, Yulia, Vargas Alvarez, Hebert A., Sarasohn, Debra M., Mironov, Svetlana, Abu-Rustum, Nadeem R., Chi, Dennis S.

Volltext

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer von Cadoo, Karen A., Grisham, Rachel N., O'Cearbhaill, Roisin E., Boucicaut, Nicole N., Henson, Melissa, Iasonos, Alexia, Zhou, Qin, Sarasohn, Debra M., Gallagher, Jacqueline, Kravetz, Sara, Zamarin, Dmitriy, Makker, Vicky, Sabbatini, Paul J., Tew, William P., Aghajanian, Carol, Konner, Jason A.

Volltext

Limitations of CT During PET/CT von Gollub, Marc J, Hong, Richard, Sarasohn, Debra M, Akhurst, Tim

Volltext

Is It Time to Centralize Ovarian Cancer Care in the United States? von Cowan, Renee A, O’Cearbhaill, Roisin E, Gardner, Ginger J, Levine, Douglas A, Roche, Kara Long, Sonoda, Yukio, Zivanovic, Oliver, Tew, William P, Sala, Evis, Lakhman, Yulia, Vargas Alvarez, Hebert A, Sarasohn, Debra M, Mironov, Svetlana, Abu-Rustum, Nadeem R, Chi, Dennis S

Volltext

Development and Baseline Characterization of a Thrombosis Risk Alert Tool: A Quality Assessment Project von Sathe, Claire M, Poon, Chester, Sarasohn, Debra M. M, Gilbert, Leah, Khorana, Alok A, Mantha, Simon, Soff, Gerald A.

Volltext

Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk von Soff, Gerald A., Batista, Jeanette, Sarasohn, Debra M. M, Mones, Jodi V, Wilkins, Cy, Haegler-Laube, Eva S, Devlin, Sean M, Miao, Yimei, Bendheim, Gemma, Wills, Jonathan, Mantha, Simon H

Volltext

Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease von Soff, Gerald A., Sarasohn, Debra M. M, Haegler-Laube, Eva S, Devlin, Sean M, Miao, Yimei, Bendheim, Gemma, Batista, Jeanette, Wills, Jonathan, Mones, Jodi V, Wilkins, Cy, Mantha, Simon H

Volltext

Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significance von Mantha, Simon, MD, MPH, Sarasohn, Debra, MD, Ma, Weining, MD, Devlin, Sean M., PhD, Chi, Dennis S., MD, Roche, Kara Long, MD, Suidan, Rudy S., MD, Woo, Kaitlin, MS, Soff, Gerald A., MD

Volltext

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2) von Lumish, Melissa, Chui, M. Herman, Zhou, Qin, Iasonos, Alexia, Sarasohn, Debra, Cohen, Seth, Friedman, Claire, Grisham, Rachel, Konner, Jason, Kyi, Chrisann, Rubinstein, Maria, Troso-Sandoval, Tiffany, Aghajanian, Carol, Makker, Vicky

Volltext

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study von Rubinstein, Maria M., Doria, Eric Rios, Konner, Jason, Lichtman, Stuart, Zhou, Qin, Iasonos, Alexia, Sarasohn, Debra, Troso-Sandoval, Tiffany, Friedman, Claire, O'Cearbhaill, Roisin, Cadoo, Karen, Kyi, Chrisann, Cohen, Seth, Soldan, Krysten, Billinson, Eric, Caird, Imogen, Jang, Dasom, Eid, Khalil, Shah, Pooja, Guillen, Joyce, Aghajanian, Carol, Zamarin, Dmitriy, Makker, Vicky

Volltext

Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma von Gerecitano, John, Portlock, Carol, Moskowitz, Craig, Hamlin, Paul, Straus, David, Zelenetz, Andrew D., Zhang, Zhigang, Dumitrescu, Otilia, Sarasohn, Debra, Lin, Dorothy, Pappanicholaou, Jennifer, Cortelli, Barbara M., Neylon, Ellen, Hamelers, Rachel, Wright, John, O’Connor, Owen A.

Volltext